Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non‐target sites, for DAA‐based treatment and retreatment outcome-Reference-Cited by-同舟云学术

Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non‐target sites, for DAA‐based treatment and retreatment outcome

Published:2020-11-25 Issue:2 Volume:28 Page:302-316
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Fahnøe Ulrik¹²,Pedersen Martin S.¹²³⁴,Sølund Christina¹⁵,Ernst Anja⁶,Krarup Henrik B.⁶⁷^ORCID,Røge Birgit T.⁸,Christensen Peer B.⁹¹⁰,Laursen Alex L.¹¹,Gerstoft Jan¹²¹³,Thielsen Peter¹⁴,Madsen Lone G.¹³¹⁵,Pedersen Anders G.¹⁶,Schønning Kristian³¹³¹⁷,Weis Nina⁵¹³,Bukh Jens¹²⁵^ORCID

Affiliation:

1. Copenhagen Hepatitis C Program (CO‐HEP), Department of Infectious Diseases Copenhagen University Hospital Hvidovre Denmark

2. Department of Immunology and Microbiology, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

3. Department of Clinical Microbiology Copenhagen University Hospital Hvidovre Denmark

4. Department of Science and Environment Roskilde University Roskilde Denmark

5. Department of Infectious Diseases Copenhagen University Hospital Hvidovre Denmark

6. Department of Molecular Diagnostics Aalborg University Hospital Aalborg Denmark

7. Department of Medical Gastroenterology Aalborg University Hospital Aalborg Denmark

8. Department of Medicine Lillebaelt Hospital Kolding Denmark

9. Department of Infectious Diseases Odense University Hospital Odense Denmark

10. Department of Clinical Research, Faculty of Health Sciences University of Southern Denmark Odense Denmark

11. Department of Infectious Diseases Aarhus University Hospital Skejby Denmark

12. Department of Infectious Diseases Copenhagen University Hospital, Rigshospitalet Copenhagen Denmark

13. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

14. Department of Gastroenterology Copenhagen University Hospital Herlev Denmark

15. Department of Medical Gastroenterology Zealand University Hospital Køge Denmark

16. Department of Health Technology, Section for Bioinformatics Technical University of Denmark Lyngby Denmark

17. Department of Clinical Microbiology Copenhagen University Hospital Rigshospitalet Denmark

Funder

Novo Nordisk Fonden

Innovationsfonden

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13430

Reference45 articles.

1. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control

2. EASL Recommendations on Treatment of Hepatitis C 2018

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C

4. From non-A, non-B hepatitis to hepatitis C virus cure

5. Implications of HCV RNA level at week 4 of direct antiviral treatments for hepatitis C

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients;Microbiology Spectrum;2024-09-03

2. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

3. Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an in vivo infectious 3b cDNA clone;Journal of Virology;2023-12-21

4. Pre‐existing, treatment‐specific resistance‐associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct‐acting antivirals;APMIS;2023-06-25

5. Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system;Hepatology;2023-04-03